Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host disease

Sherrie J. Divito(Brigham and Women's Hospital), Thomas S. Kupper(Brigham and Women's Hospital), Rachael A. Clark(Brigham and Women's Hospital), Jude Hilaire, John T. O’Malley(Brigham and Women's Hospital), Henrik M. Reims(Oslo University Hospital), Martín C. Mihm(Harvard University), Corey Cutler(Harvard University), Vincent T. Ho(Dana-Farber Cancer Institute), Matthew Collin(Newcastle upon Tyne Hospitals NHS Foundation Trust), Haesook T. Kim(Dana-Farber Cancer Institute), Pei‐Chen Hsieh(Chang Gung Memorial Hospital), Frode L. Jahnsen(Oslo University Hospital), Christopher P. Elco(Brown University), Tobias Gedde‐Dahl, Espen S. Bækkevold(Oslo University Hospital), Robert J. Soiffer(Dana-Farber Cancer Institute), Anders Theodor Aasebo(Oslo University Hospital), Tiago R. Matos(Sanofi (Netherlands)), Michael Hagerstrom, Indira Guleria(Brigham and Women's Hospital), Edgar L. Milford(Brigham and Women's Hospital), Jerome Ritz(Dana-Farber Cancer Institute), Geraldine S. Pinkus(Brigham and Women's Hospital), John W. Lian(Brigham and Women's Hospital)
Journal of Clinical Investigation
June 9, 2020
Cited by 86


Related Papers